Portfolio company
IVIVA Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioartificial implantable kidneys for patients with end-stage renal disease using 3D printing and stem cell technology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
iRiva Medical
This company develops implantable neuromodulation technology platforms to treat patients suffering from chronic diseases.
VenoStent
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
Satellite Bio
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
Dimension Bio
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
XS Innovations
This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.